Evidence map›Paper›PMID 36054678›Full record

ArticleAutism research : official journal of the International Society for Autism Research2022

Replication study for ADOS-2 cut-offs to assist evaluation of autism spectrum disorder.

Ji Su Hong, Vini Singh, Luke Kalb, Rachel Reetzke, Natasha N Ludwig, Danika Pfeiffer, Calliope Holingue, Deepa Menon, Qing Lu, Ahlam Ashkar and 1 more

Open access · greenAbstract read
In one paragraph

Article in Autism research : official journal of the International Society for Autism Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ji Su HongCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0002-3866-1635
Vini SinghCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Luke KalbCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Rachel ReetzkeCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Natasha N LudwigDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Danika PfeifferCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Calliope HolingueCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Deepa MenonCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Qing LuCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Ahlam AshkarCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Rebecca LandaCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Kennedy Krieger Institute · US

Funding

Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
NICHD NIH HHS P50 HD103538
6 · The paper itself

Abstract

The Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) has been widely used for ASD assessment. While prior studies investigated sensitivity and specificity of ADOS-2 Modules 1-3, there has been limited research addressing algorithm cut-off scores to optimize ADOS-2 classification. The goal of this study was to assess algorithm cut-off scores for diagnosing ASD with Modules 1-3, and to evaluate alignment of the ADOS-2 classification with the best estimate clinical diagnosis. Participants included 3144 children aged 31 months or older who received ADOS-2 Modules 1-3, as well as the best estimate clinical diagnosis. Five classification statistics were reported for each module: sensitivity, specificity, positive predictive value, negative predictive value, and accuracy (i.e., Receiver Operator Classification Statistic), and these statistics were calculated for the optimal cut-off score. Frequency tables were used to compare ADOS-2 classification and the best estimate clinical diagnosis. Half of the sample received Module 3, 21% received Module 2, and 29% received Module 1. The overall prevalence of ASD was 60%; the male-to-female ratio was 4:1, and half of the sample was non-White. Across all modules, the autism spectrum cut-off score from the ADOS-2 manual resulted in high sensitivity (95%+) and low specificity (63%-73%). The autism cut-off score resulted in better specificity (76%-86%) with favorable sensitivity (81%-94%). The optimal cut-off scores for all modules based on the current sample were within the autism spectrum classification range except Module 2 Algorithm 2. In the No ASD group, 29% had false positives (ADOS-2 autism spectrum classification or autism classification). The ADOS-2 autism spectrum classification did not indicate directionality for diagnostic outcome (ASD 56% vs. No ASD 44%). While cut-off scores of ADOS-2 Modules 1-3 in the manual yielded good clinical utility in ASD assessment, false positives and low predictability of the autism spectrum classification remain challenging for clinicians.

Indexed as

Autism Spectrum DisorderAutistic DisorderAlgorithmsChildFemaleHumansMalePredictive Value of TestsSensitivity and Specificityautism spectrum disorderclassificationcut-off scorediagnosis

Identifiers

PMID36054678
PMCPMC10246880
OpenAlexW4294191200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.